Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2.

Asai, Ayumu; Koseki, Jun; Konno, Masamitsu; Nishimura, Tatsunori; Gotoh, Noriko; Satoh, Taroh; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi

Asai, Ayumu; Koseki, Jun; Konno, Masamitsu; Nishimura, Tatsunori; Gotoh, Noriko; Satoh, Taroh; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi.

Afiliación

Asai A; Department of Medical Data Science, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Koseki J; Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Konno M; Department of Gastroenterological Surgery Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Nishimura T; Department of Medical Data Science, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Gotoh N; Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Satoh T; Division of Cancer Cell Biology, Cancer Research Institute, Kanazawa University, Kanazawa 920-1192, Japan.
Doki Y; Division of Cancer Cell Biology, Cancer Research Institute, Kanazawa University, Kanazawa 920-1192, Japan.
Mori M; Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Ishii H; Department of Medical Data Science, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.

Heliyon ; 4(12): e01021, 2018 Dec.

Article en En | MEDLINE | ID: mdl-30582043

Palabras clave

Cancer research; Molecular biology; Pharmaceutical science

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Heliyon Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google